Table 1.
Selected animal models of CIBP.
| SPECIES AND STRAIN | TUMOR CELL LINE | TUMOR CELL TISSUE OF ORIGIN | INJECTION | SYNGENEIC | REFERENCES |
|---|---|---|---|---|---|
| Mouse | |||||
| BALB/c | 66.1 | Mammary Pad—adenocarcinoma (Murine) | Femur | X | 101 |
| BALB/cJ | 4T1 | Mammary Pad—adenocarcinoma (Murine) | Femur | X | 165 |
| B6C3/F1 | NCTC 2472 | Mesenchyme—Osteosarcoma (Murine) | Humerus | X | 166 |
| C57BL/6 | Lewis Lung | Lung—Carcinoma (Murine) | Femur | X | 167 |
| C57BI/6J | MC57G | Fibrosarcoma (Murine) | Femur | X | 27 |
| CDF1 | Colon-26 | Colon—adenocarcinoma (murine) | Intracardiac | X | 41 |
| C3H/He | NCTC 2472 | Mesenchyme—Osteosarcoma (Murine) | Humerus | X | 166 |
| Calcaneus | X | 168 | |||
| C3H/HeN | NCTC 2472 | Mesenchyme—Osteosarcoma (Murine) | Femur | X | 165, 169 |
| C3H/HeNCr | NCTC 2472 | Mesenchyme—Osteosarcoma (Murine) | Calcaneus | X | 170 |
| C3H/HeJ | NCTC 2472 | Mesenchyme—Osteosarcoma (Murine) | Femur | X | 77, 78, 105 |
| Tibia | X | 171 | |||
| C3H/SCID | 4T1 | Mammary Pad—adenocarcinoma (Murine) | Femur | 68 | |
| SCID | PC3N | Prostate—carcinoma (Human) | Femur | 172 | |
| Nude nu/nu | ACE-1 | Prostate—adenocarcinoma (Canine) | Intracardiac | 173 | |
| Femur | 68, 71, 75 | ||||
| MDA-MB-231 | Breast—adenocarcinoma (Human) | Intracardiac | 41, 56 | ||
| Mammary Pad | 45 | ||||
| Femur | 87 | ||||
| MDA-MB-231-TXSA | Breast—adenocarcinoma, OPG overexpressing (Human) | Tibia | 42 | ||
| Rat | |||||
| Sprague-Dawley | MRMT1 | Mammary Pad—gland carcinoma cells (Rat) | Tibia | X | 24 |
| Walker 256 | Mammary Gland—carcinoma (Rat) | Tibia | X | 82, 110, 111, 114, 174 | |
| Copenhagen | AT-3 | Prostate—adenocarcinoma (Rat) | Tibia | X | 175 |
| Wistar | MRMT1 | Mammary Pad—gland carcinoma cells (Rat) | Tibia | 81 | |